1. Institute of Medical Biochemistry, Centre for Molecular Biology of Inflammation, University of Muenster, Muenster, Germany;
2. Biopharmaceutical Research Unit, Novo Nordisk A/S, Maløv, Denmark; and
3. Max Planck Institute for Molecular Biomedicine, Muenster, Germany